PAPA (Papa Medical) YoY EBITDA Growth: 97.06% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Papa Medical YoY EBITDA Growth?

Papa Medical PAPA YoY EBITDA Growth is 97.06% as of Mar. 2025.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Papa Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 97.06%.

Papa Medical's EBITDA per Share for the three months ended in Mar. 2025 was $0.07.

Papa Medical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Papa Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical YoY EBITDA Growth Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
YoY EBITDA Growth
0.00 54.29 0.93

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only 0.00 -45.45 10.71 -66.67 97.06

Papa Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Papa Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.109-0.108)/ | 0.108 |
=0.93 %

Papa Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.067-0.034)/ | 0.034 |
=97.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 97.06% mean?
Papa Medical (PAPA) has a YoY EBITDA Growth of 97.06% as of Mar. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Papa Medical and its competitors.
Is Papa Medical's YoY EBITDA Growth too high?
Papa Medical's current YoY EBITDA Growth is 97.06%.
How does Papa Medical's YoY EBITDA Growth compare to ?
Papa Medical's YoY EBITDA Growth of 97.06% can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Tobacco Products company?
A good YoY EBITDA Growth depends on the Tobacco Products industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Papa Medical and its competitors. Papa Medical's current YoY EBITDA Growth is 97.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current YoY EBITDA Growth of 97.06%. The current YoY EBITDA Growth is 97.06%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Papa Medical (PAPA), the current YoY EBITDA Growth is 97.06% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.